Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.010 Biomarker disease BEFREE Some NPS proxies, including NPI-Q total severity score, NPI-Q total stress score, and GDS-15 total score, were deemed as the most important variables for predicting conversion, adding further support to the hypothesis that some NPS are associated with a higher risk of dementia in MCI. 31455461 2020
Entrez Id: 10482
Gene Symbol: NXF1
NXF1
0.010 Biomarker disease BEFREE Findings suggest that TAP-O may be an effective nonpharmacological strategy to reduce NPS of outpatients with dementia and to minimize caregiver burden. 30035341 2019
Entrez Id: 23541
Gene Symbol: SEC14L2
SEC14L2
0.010 Biomarker disease BEFREE Findings suggest that TAP-O may be an effective nonpharmacological strategy to reduce NPS of outpatients with dementia and to minimize caregiver burden. 30035341 2019
Entrez Id: 8615
Gene Symbol: USO1
USO1
0.010 Biomarker disease BEFREE Findings suggest that TAP-O may be an effective nonpharmacological strategy to reduce NPS of outpatients with dementia and to minimize caregiver burden. 30035341 2019
Entrez Id: 2317
Gene Symbol: FLNB
FLNB
0.010 Biomarker disease BEFREE Findings suggest that TAP-O may be an effective nonpharmacological strategy to reduce NPS of outpatients with dementia and to minimize caregiver burden. 30035341 2019
Entrez Id: 3060
Gene Symbol: HCRT
HCRT
0.010 AlteredExpression disease BEFREE We observed higher CSF orexin levels in AD/NPS+ than AD/NPS-patients. 30372684 2018
Entrez Id: 5599
Gene Symbol: MAPK8
MAPK8
0.010 Biomarker disease BEFREE Immunohistochemistry indicated that c-jun N-terminal kinase and Caspase-3 were increased in NPS tumor tissues in xenograft models treated with LEB and I-131. 30233679 2018
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.010 GeneticVariation disease BEFREE NPS in the MAPT group were mainly associated with volume loss in the temporal lobe. 30010122 2018
Entrez Id: 836
Gene Symbol: CASP3
CASP3
0.010 Biomarker disease BEFREE Immunohistochemistry indicated that c-jun N-terminal kinase and Caspase-3 were increased in NPS tumor tissues in xenograft models treated with LEB and I-131. 30233679 2018
Entrez Id: 8809
Gene Symbol: IL18R1
IL18R1
0.010 Biomarker disease BEFREE In the Ag-NPS-treated group, 78 biological functions were changed based on gene ontology (GO) and 34 signaling pathways were significantly changed using Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, which were associated with the neuroactive ligand-receptor interaction, cytokine-cytokine receptor interaction, calcium signaling pathway and MAPK signaling pathway. 29944106 2018
Entrez Id: 28954
Gene Symbol: REM1
REM1
0.010 Biomarker disease BEFREE Moreover, AD/NPS+ showed a more fragmented and the reduction of REM sleep compared to AD/NPS-patients. 30372684 2018
Entrez Id: 10148
Gene Symbol: EBI3
EBI3
0.010 Biomarker disease BEFREE In the Ag-NPS-treated group, 78 biological functions were changed based on gene ontology (GO) and 34 signaling pathways were significantly changed using Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, which were associated with the neuroactive ligand-receptor interaction, cytokine-cytokine receptor interaction, calcium signaling pathway and MAPK signaling pathway. 29944106 2018
Entrez Id: 387129
Gene Symbol: NPSR1
NPSR1
0.010 AlteredExpression disease BEFREE We speculate that NPS significantly reduces anesthetic-induced SWS and EEG slow activity by selective activation of the NPSR, which, in turn, would trigger subsequent arousal pathways. 28228241 2017
Entrez Id: 3606
Gene Symbol: IL18
IL18
0.010 Biomarker disease BEFREE The significant biomarkers differed for carriers and non-carriers with IL15 being a negative biomarker of total NPS accounting for 12% of the variance for carriers and IL18 and TNFα negative predictors for non-carriers (18% of variance). 24577461 2014
Entrez Id: 3600
Gene Symbol: IL15
IL15
0.010 Biomarker disease BEFREE The significant biomarkers differed for carriers and non-carriers with IL15 being a negative biomarker of total NPS accounting for 12% of the variance for carriers and IL18 and TNFα negative predictors for non-carriers (18% of variance). 24577461 2014
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.010 Biomarker disease BEFREE The significant biomarkers differed for carriers and non-carriers with IL15 being a negative biomarker of total NPS accounting for 12% of the variance for carriers and IL18 and TNFα negative predictors for non-carriers (18% of variance). 24577461 2014
Entrez Id: 2692
Gene Symbol: GHRHR
GHRHR
0.010 GeneticVariation disease BEFREE No OTX2 abnormality was detected in PSIS patients, and no GH1 or GHRHR polymorphisms in NPS patients. 23199197 2013
Entrez Id: 2516
Gene Symbol: NR5A1
NR5A1
0.010 GeneticVariation disease BEFREE This suggests that the locus 9q33-9q34 can be excluded for GPS and that the presented case is unique in its combination of GPS and NPS features caused by a microdeletion associated with loss of function of LMX1B and NR5A1. 17431898 2007
Entrez Id: 4210
Gene Symbol: MEFV
MEFV
0.010 GeneticVariation disease LHGDN Co-occurrence of familial Mediterranean fever (FMF) heterozygote mutation and nail-patella syndrome (NPS) in 3 members of a family with LMX1B mutation analysis. 17710881 2007
Entrez Id: 23607
Gene Symbol: CD2AP
CD2AP
0.010 Biomarker disease BEFREE These findings indicate that heterozygous mutations of LMX1B do not appear to dramatically affect the expression of type IV collagen chains, podocin, or CD2AP in NPS patients. 12819019 2003
Entrez Id: 8830
Gene Symbol: PTLAH
PTLAH
0.010 Biomarker disease BEFREE PTLAH can occur either as an isolated defect or in association with other malformations, and it characteristically occurs in the nail-patella syndrome and in some chromosome imbalances. 10417287 1999
Entrez Id: 594857
Gene Symbol: NPS
NPS
0.010 GeneticVariation disease BEFREE Mouse Lmx1b maps to a region syntenic to that of the NPS gene, and kidneys of Lmx1b mutant mice exhibit pathological changes similar to that observed in NPS (refs 5,6). 9590288 1998
Entrez Id: 25
Gene Symbol: ABL1
ABL1
0.010 Biomarker disease BEFREE By using FISH with probes from 9q the breakpoint region was narrowed to a 17.0 cM interval between D9S262 and ABL, which includes the NPS critical region. 9781017 1998
Entrez Id: 4547
Gene Symbol: MTTP
MTTP
0.010 Biomarker disease BEFREE By using FISH with probes from 9q the breakpoint region was narrowed to a 17.0 cM interval between D9S262 and ABL, which includes the NPS critical region. 9781017 1998
Entrez Id: 445
Gene Symbol: ASS1
ASS1
0.010 GeneticVariation disease BEFREE Haplotype analysis suggested an additional recombination between NPS and the argininosuccinate synthetase (ASS) gene. 7825584 1995